http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
bridging basic science with clinical medicine
1 online resource (xliii, 1084 pages) : illustrations.
This volume in Advances in Pharmacology focuses on all aspects of catecholamine research, from very basic to medical. It is broad based and covers many areas within physiology and medicine.
Front Cover; Catecholamines: Bridging Basic Science with Clinical Medicine; Copyright Page; Contents; Contributors; Preface; PART A: CATECHOLAMINE SYNTHESIS AND RELEASE; Overview; Section I: Regulation and Expression of Tyrosine Hydroxylase; Chapter 1. The Effect of Phosphorylation at Ser-40 on the Structure and Thermal Stability of Tyrosine Hydroxylase; Chapter 2. Factors Affecting Adrenal Medullary Catecholamine Biosynthesis and Release; Chapter 3. Regulation of Tyrosine Hydroxylase by Neuropeptides.
Chapter 4. Regulation of Tyrosine Hydroxylase Gene Expression by Transsynaptic Mechanisms and Cell-Cell ContactChapter 5. A New Regulatory Protein of Catecholamine Synthesizing- Enzyme Expression; Chapter 6. Unique and Cell-Type-Specific Tyrosine Hydroxylase Gene Expression; Chapter 7. Triple Colocalization of Tyrosine Hydroxylase, Calretinin, and Calbindin D-28k in the Periventricular-Hypophyseal Dopaminergic Neuronal System; Chapter 8. Genetic Disorders Involving Recycling and Formation of Tetrahydrobiopterin; Chapter 9. Genetic Basis of Dominant Dystonia.
Chapter 10. Mutations in the Tyrosine Hydroxylase Gene Cause Various Forms of L-Dopa-Responsive DystoniaChapter 11. Catecholamine Biosynthetic Enzyme Expression in Neurological and Psychiatric Disorders; Section II: Other Catecholamine-Synthesizing Enzymes; Chapter 12. Multiple Pathways in Regulation of Dopamine ß-Hydroxylase; Chapter 13. Examining Adrenergic Roles in Development, Physiology, and Behavior through Targeted Disruption of the Mouse Dopamine ß-Hydroxylase Gene; Chapter 14. Genetic Diseases of Hypotension.
Chapter 15. Dopamine ß-Hydroxylase Deficiency Associated with Mutations in a Copper Transporter GeneChapter 16. Glucocorticoid-Phenylethanolamine-N-methyltransferase Interactions in Humans; Chapter 17. Determinants of Phenylethanolamine-N- methyltransferase Expression; Chapter 18. Neural Control of Phenylethanolamine-N- methyltransferase via Cholinergic Activation of Egr- I; Chapter 19. Synexin (Annexin VII) Hypothesis for Ca2+/GTP-Regulated Exocytosis; Chapter 20. Monoamine Transmitter Release from Small Synaptic and Large Dense-Core Vesicles.
Chapter 21. Calcium Channels for Exocytosis in Chromaffin CellsChapter 22. Characteristics of Transmitter Secretion from Individual Sympathetic Varicosities; Chapter 23. Neurotransmitter Release at Individual Sympathetic Varicosities, Boutons; Chapter 24. Appropriate Target Cells Are Required for Maturation of Neurotransmitter Release Function of Sympathetic Neurons in Culture; Chapter 25. Effects of Neuropeptide Y at Sympathetic Neuroeffector Junctions; Chapter 26. Strategies for Receptor Control of Neurotransmitter Release.
edited by David S. Goldstein, Graeme Eisenhofer, Richard McCarty.
Includes bibliographical references and index.
Catecholamines : Bridging Basic Science with Clinical Medicine